Events
13 January 2011: EU funding for Public Health projects |
|
|
Venue: EPIC Centre, Norwich Event hosted by EEDA |
Meeting
0930 :
13 January 2011
Keywords
Public Health |
| Contact : | |
17 January 2011: The End of the HFEA: are we throwing the baby out with the bathwater? |
|
|
Venue: Royal Society, London |
Debate
1830 - 2030 :
17 January 2011
Keywords
Reproductive Issues |
| Contact : | |
20 January 2011: International Workshop on Genomics of Health and Diseases |
|
|
Venue: Natal, Brazil |
Workshop
20 January 2011
Keywords
Genomics |
| Contact : | |
25 January 2011: Gordon Research Conference - Cancer Genetics and Epigenetics |
|
|
Venue: Ventura, California, USA |
4 day event :
25 January 2011
to
28 January 2011
Keywords
Genetics |
| Contact : | |
27 January 2011: Later Life - Planning for an Ageing Population |
|
|
Venue: The Barbican, London The Department of Health has recently published its 'Vision for Adult Social Care', setting out the government's plans for reforming social care. The report from the Commission for the Funding of Care and Support will aim to answer the key question of how health and social care for the elderly should be paid for. |
Conference
27 January 2011
Keywords
Health Service |
| Contact : | |
30 January 2011: Keystone Symposium - Genomic Instability and DNA Repair |
|
|
Venue: Keystone, Colorado, USA |
Symposium
6 day event :
30 January 2011
to
4 February 2011
Keywords
Genomics |
| Contact : | |
31 January 2011: Biomarkers Summit - SMi Group |
|
|
Venue: London UK SMi Group is proud to announce their 4th annual Biomarkers Summit... It is now clear that the use of biomarkers is an integral part in the future of medicine. With rising development costs and a declining rate of new drug discovery, pharmaceutical companies are now incorporating biomarker strategies into all new R&D processes. With the industry currently realising the benefits to be had from joint R&D projects and key collaborations, it is now estimated that the Biomarker market value will reach over $12.8 Billion dollars by 2012. Likewise the level of innovation in Biomarker applications and translational science is seeing increasingly rapid growth. With new discoveries being made in every therapeutic category, Biomarkers are promising to drive forward new drug discovery, companion diagnostics, and to wholly improve patient outcomes. |
Conference
2 day event :
31 January 2011
to
1 February 2011
|
| Contact : | |